We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Device Speeds Sample Preparation

By Biotechdaily staff writers
Posted on 02 Sep 2005
A new dielectrophoretic device may revolutionize sample preparation by delivering detectable amounts of material in small water sample volumes, eliminating any need for overnight culturing and speeding up overall water analysis.

The insulator-based dielectrophoretic device (iDEP) concentrates live pathogenic bacteria within large water samples. More...
In addition to water analysis, the technology may also have applications beneficial to a host of other applications. The technology was developed by researchers at Sandia [U.S.] National Laboratories (Livermore, CA, USA).

The scientists at Scandia are developing application-specific iDEP devices and architectures for concentrating and separating bacteria, spores, viruses, and other particles. iDEP could also enable verification of biologic decontamination efficacy for viable cell populations, as contrasted to inactivated cells and denatured proteins. For public health purposes, it could improve water analysis and spore and vegetative cell differentiation. In addition, iDEP could separate nanoparticles and nanotubes for materials synthesis.

Scandia is seeking commercial partners to further develop the technology to differentiate between live and dead cells for cell culturing; to sort anomalous cells to diagnose diseases such as cancer, sickle cell anemia, and leukemia; and to concentrate and focus on samples for proteomics research and drug discovery.

"In laboratories, iDEP could contribute to differential sorting of live and dead cells in cell culturing, and allow for protein isolation and concentration, sample concentration and focusing, analytical chemistry, and mass spectrometry for proteomics and drug discovery,” observed Carrie Burchard, a business development manager at Sandia.




Related Links:
Sandia Nat'l Laboratories

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.